TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/25 16:30 | 2/11/25 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 31 | 17 | 214 | D | ||||||||||||||
11/22/24 09:00 | 11/21/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 24 | 0.6000 | 0 | 40 | 26 | 195 | D | ||||||||||||||
5/28/24 09:11 | 5/24/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | P | 11 | 1.05 | 0 | 10 | 7 | 155 | D | ||||||||||||||
2/12/24 21:27 | 2/11/24 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 31 | 28 | 145 | D | ||||||||||||||
2/14/23 16:15 | 2/11/23 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 31 | 33 | 126 | D | ||||||||||||||
6/30/22 17:57 | 6/30/22 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Culley Brian M | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 15 | 17 | 108 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |